Clarithromycin-idarubicin.
Harvengt
C
C
Laboratoire de Pharmacothérapie, Cliniques Universitaires St-Luc, Bruxelles.
D017291:Clarithromycin; D004917:Erythromycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D004917:Erythromycin; D017291:Clarithromycin; D015255:Idarubicin